期刊文献+

IL-18基因修饰人脐带间充质干细胞对乳腺癌细胞系增殖的影响 被引量:3

Effect of interleukin-18 gene modified human umbilical cord mesenchymal stem cells on proliferation of breast cancer cell
原文传递
导出
摘要 目的:建立携带白细胞介素18(IL-18)基因人脐带间充质干细胞(HUMSCs)株并探讨其对乳腺癌细胞增殖的影响。方法分离培养HUMSCs,慢病毒介导IL-18基因转染HUMSCs建立携带 IL-18基因人脐带间充质干细胞( IL-18-HUMSCs )株,半定量 RT-PCR 及 Western 印迹检测IL-18mRNA及蛋白表达情况。 Transwell体系共培养后第1、3、5天用Cell Counting Kit-8(CCK-8)试剂盒检测MCF-7细胞增殖活力,绘制细胞生长曲线。结果 IL-18-HUMSCs能稳定高效表达IL-18基因,并有效抑制乳腺癌细胞增殖。其 IL-18 mRNA 相对表达量为:实验组( IL-18-HUMSCs )1.40±0.21,阴性对照组(NV-HUMSCs)0.59±0.09,空白对照组(HUMSCs)0.71±0.05;与各对照组比较,差异有统计学意义(F=31.81,P=0.001)。 IL-18蛋白相对表达量为:实验组(IL-18-HUMSCs)1.54±0.27,阴性对照组(NV-HUMSCs)0.57±0.04,空白对照组(HUMSCs)0.59±0.23;与各对照组比较,差异有统计学意义( F=22.32, P=0.002)。共培养后第5天,乳腺癌细胞增殖受到明显抑制。结论HUMSCs是IL-18基因高效稳定表达载体,IL-18-HUMSCs可有效抑制乳腺癌细胞增殖。 Objective To establish human umbilical cord mesenchymal stem cells ( HUMSCs ) strain transfected with interleukin-18 ( IL-18 ) gene and examine its effects on the proliferation of breast cancer cell ( MCF-7 ).Methods HUMSCs were isolated and cultured.And the lentivirus-IL-18 vector containing human IL-18 gene was constructed and transfected into HUMSCs.The expressions of IL-18 gene mRNA and protein were detected by semi-quantitative reverse transcription-polymerase chain reaction ( RT-PCR) and Western blot.After co-culturing for 1,3,5 days,Transwell and cell counting kit-8(CCK-8)assays were performed on MCF-7 to plot the cell growth curve.Results IL-18-HUMSCs could stably express of IL-18 gene and inhibit the proliferation of breast cancer cells.The IL-18 mRNA relative expression amounts were 1.40 ±0.21 for experimental group ( IL-18-HUMSCs ) , 0.59 ±0.09 for negative control group ( NV-HUMSCs) and 0.71 ±0.05 for blank control group ( HUMSCs ).As compared with control group , the difference was statistically significant ( F=31.81,P=0.001).The relative expressions of IL-18 protein were 1.54 ±0.27 for experimental group ( IL-18-HUMSCs ) , 0.57 ±0.04 for negative control group ( NV-HUMSCs) and 0.59 ±0.23 for blank control group ( HUMSCs ).As compared with control group , the difference was statistically significant ( F =22.32, P =0.002 ).After co-culturing for 5 days, the cellular proliferation was significantly inhibited.Conclusion IL-18 gene has been successfully transfected into HUMSCs and has a stable expression.And IL-18-HUMSCs can effectively inhibit the proliferation of breast cancer cells in vitro.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第26期2013-2017,共5页 National Medical Journal of China
基金 国家自然科学基金(81302290) 山东省自然科学基金(ZR2013HM019)
关键词 乳腺肿瘤 白细胞介素-18 人脐带间充质干细胞 CCK-8试验 Breast neoplasms Interleukin-18 Human umbilical cord mesenehymal stromal cells Cell counting kit-8 assay
  • 相关文献

参考文献13

  • 1Khakoo AY, Pali S, Anderson SA ,et al. Human mesenehymal stem ceils exert potent antitumorigenic effects in a model ol" Kaposi's sarcoma[J]. J Experimental Medicine, 2006,203 : 1235-1247.
  • 2Lebinger MR, Eddaoudi A, Davies D, et al. Mesenchymal stem cell delivery of TRAIl, can eliminate metastatic cancer[ J]. Cancerresearch ,2009,69 : 4134-4142.
  • 3Shah K. Mesenchymal stem cells engineered for cancer therapy [ J]. Advanced Drug Delivery Reviews,2012,64: 739-748.
  • 4Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem ceils derived from umbilical cord and bone marrow [ J ] . Stem Cells,2007,25 : 1384-1392.
  • 5Yoo KH, Jang IK, Lee MW, et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues [ J ] . Cellular Immunology, 2009,259 : 150-156.
  • 6Wang L, Tran I, Seshareddy K, et al. A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering [ J]. Tissue Engineering Part A,2009,15 : 2259-2266.
  • 7Kucerova L, Altanerova V, Matuskova M, et al. Adipose tissue- derived human mesenchymal stem cells mediated pro-drug cancer gene therapy[ J]. Cancer Research,2007,67 : 6304-6313.
  • 8Apel A, Groth A, Schlesinger S, et al. Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium[ J]. Experimental Cell Research,2009,315: 498-507.
  • 9Yao L, Zhang Y, Chen K, et al. Discovery of IL-18 as a novelsecreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox [J]. PloS One,2011,6 : e24684.
  • 10成兵,农绍军,张跃平.重组腺病毒介导白细胞介素18、12联合基因治疗前列腺癌的实验观察[J].中华医学杂志,2013,93(20):1590-1593. 被引量:4

二级参考文献15

  • 1Shaojun N, Duaugai W, Caibin F, et al. Clinical value of serum interleukin-18 in patients with prostate cancer. Chinese-Gernlan J Clinical Oncol,2007, 6:574-578.
  • 2Shaojun N, Yueping Z, Shujun Z, et al, Relationship between serum IL-18 and VEGF levels in patients with prostate cancer. Chinese-German J Clinical Oncol, 2010, l1:643-647.
  • 3Mittal S, Bert AJ, Prevec L , et al. Foreign gene expression by human adenovirus type-5 based vectors studied using firefly luciferaseand bacterial beta-galactosidase gene as reporters. Virology, 1995, 210: 226-230.
  • 4Shao DZ, Qing H, Fan Z, et al. Monitoring HSV-TK/ganciclovir cancer suicide gene therapy using CdTe/CdS core/shell quantum dots. Biomaterials,2012,33 : 4336-4344.
  • 5Di Matteo M, Belay E, Chuah MK, et al. Recent developments in transposon-mediated gene therapy. Expert Opinion Biological Therapy, 2012, 12: 841-858.
  • 6Heidemann SC, Chavez V, Landers C J, et al. TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK- resistant tumor targets. J Clin Immunol.2010. 30:531-538.
  • 7Zheng JN, Pei DS, Mao LJ, et al. Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angJogenesis. Cancer gene therapy, 2010, 17:28-36.
  • 8Kang JS, Bae SY, Kim HR, et al. interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CIM4. Carcinogenesis, 2009,30 : 1987-1996.
  • 9Wang L, Yao B, Li Q, et al. Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models. Human Gene Therapy, 2011, 22: 1061-1069.
  • 10Li Y, Li LJ, Zhang ST, et al. In vitro and clinical studies of gene therapy with recombinant human adenovirus-p53 injection for oral leukoplakia. Clin Cancer Res,2009, 15 : 6724-6731.

共引文献3

同被引文献37

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部